OEM News

Navigating Thailands Medical Device Market

Navigating Thailand's Medical Device Market

Navigating Thailand’s Medical Device Market

 

 

Despite the horrible flooding in Thailand recently, the medical device market continues to grow. The market currently is valued at $1.6 billion and is growing at about 10 percent per year. As

Thailand continues to develop, the population’s healthcare demands will increase, and the size of the device market will continue to grow.


Market expansion primarily will be driven by upgrades to existing healthcare facilities. Although public hospitals remain the largest purchaser of medical devices in Thailand at about 60 percent of total

purchases, private hospitals in particular increasingly are looking to acquire cutting-edge medical equipment to enhance their existing facilities.


With about 66 percent of the total device market made up of imported medical devices and equipment, Thailand is dependent on imports for facility upgrades. This especially is true for high-end, sophisticated medical devices. Locally manufactured medical devices tend to be less sophisticated and more labor intensive and include surgical latex gloves, disposable syringes, orthopedic accessories, and disposable test kits.


Currently, the best prospects for medical devices in Thailand tend to be those used in the diagnosis or treatment of heart and lung disease, as well as equipment used in surgical procedures.


The devices with the highest demand include heart valves, respiratory devices, neurosurgical devices, diagnostic testing devices, orthopedic implant devices, and disposable diagnostic test kits. Demand for dermatological devices also is expected to grow. The number of dermatological clinics in Thailand has grown dramatically as skin care becomes increasingly popular in Thailand.


Medical Device Classifications


The Medical Device Control Division of the Thai Food and Drug Administration (FDA) is responsible for the regulation of medical devices in Thailand. Medical devices in Thailand are broken down into three classes: Class I, II and III. However, unlike the U.S. Food and Drug Administration, the classifications are reversed. Class 1 medical devices are the most regulated and Class 3 medical devices are the least regulated.


Class I medical devices are called “License” medical devices because they are the only medical products requiring full registration with the Thai FDA before manufacture or sale in Thailand. For example, seven devices are listed by the Thai FDA under the Class I category. They include HIV test kits for diagnosis, insulin disposable syringes, contact lenses, examination gloves, and surgical gloves.


Class II medical devices also are clearly listed by the Thai FDA regulations. The five medical devices currently regulated as Class II products include HIV test kits for research and study, breast enhancement products, alcohol detectors, implanted silicone breast prosthesis, and physical therapy products. The Thai FDA calls this category of medical devices “Notification” medical devices because they do not require full registration, but the Thai FDA needs to be notified with the appropriate documents prior to marketing or importing.


If a medical device is not one of the products specifically mentioned in Class I or II, it will fall under Class III, regardless of risk. Because the Thai FDA provides an official list (with only a limited number of devices) of specific Class I and II medical devices, most medical devices in Thailand will be classified as Class III products. Class III medical devices are “General” medical devices and do not require full product registration in Thailand.


Product Registration


The requirements for registration of imported medical devices in Thailand depend on the classification of the device. For example, to sell Class III medical devices in Thailand, the Thai FDA requires a local entity, a general import license, and a product specific import license.


A local entity with its business registered with the Thai government can be a foreign device manufacturer’s subsidiary, a distributor, or an independent third party.


The general import license is a government issued license that allows a local entity to import all kinds of general medical devices into Thailand. Many companies, consultants and distributors in Thailand already have a general import license, so foreign medical device companies (those without an office in Thailand) most likely will not have to obtain this license themselves.


The product-specific import license allows an importer to bring a specific product into Thailand. For applications to the product-specific import license, the Thai FDA requires documents such as the

Certificate of Free Sale, a company’s commercial registration, a Certificate ofIncorporation or Partnership stating the company’s objectives, etc. Implanted Class III medical devices also will need to include a GMP (good manufacturing practices) certificate or an ISO 13485 certification in their product-specific import license application.


A Certificate of Free Sale/Certificate to Foreign Governments submitted to the Thai FDA for the product specific import license should indicate the product is allowed to be sold in the manufacturing country, include the name of the manufacturer, and list the name of the medical device with information such as its model, type or product code.


If all the documents discussed above can be submitted in perfect condition, the product-specific import license can be received in only one day. However, the Thai FDA often will place a request for missing or supplementary documents if it finds that required documents are faulty or not included in the application.Thus, it normally takes the Thai FDA approximately three to five months to issue the product-specific import license.


Once a manufacturer or the legal agent has obtained the product-specific import license from the Thai FDA, the department will notify the Thai Customs Department to permit clearance of the Class III “General” medical device when it arrives in Thailand.

 

Ames Gross is president and founder of Pacific Bridge Medical, a Bethesda, Md.-based consulting firm that helps medical companies doing business in the Asia market. A recognized national and international leader in the Asian medical markets, he founded Pacific Bridge Medical in 1988. For more information, visit www.pacificbridgemedical.com.


More News from Asia


Accellent Opens Manufacturing Facilityin Malaysia


Accellent Inc., a provider of outsourced manufacturing and engineering services to the medical device industry, has opened a 65,000-square-foot manufacturing plant in Penang, Malaysia.


The new facility is joining plants in five countries. Accellent currently has 14 manufacturing facilities in 12 U.S. states as well as manufacturing operations in Germany, Ireland, Mexico and the United Kingdom.


“This site will serve as an important hub for our Asia business since several of our key customers are located nearby,” said Donald Spence, president and CEO of Accellent. “We also expect that this new facility will provide cost-effective solutions for our other global markets and help support our proven track record of bringing customer innovations to market quickly and efficiently.”


The company provides fully integrated outsourced manufacturing services as well as engineering design, prototyping, assembly, and logistics support to medical device companies in various markets, including cardiology, endoscopy, orthopaedic, and neuromodulation.


The company chose Penang both to be close to the growing Asian market and because of the stable political environment, officials said. In addition, Accellent was able to purchase and transform the plant in less than 12 months as a result of support from organizations such as the Malaysian Industrial Development Authority, Invest Penang, and several departments within the State Government of Penang.


“The Penang state government wants to transform Penang into an international and intelligent city, a preferred destination for foreign direct investment,” said Yab Tuan Lim Guan Eng, chief minister of Penang.
“We are seeking to broaden our manufacturing base by diversifying into services. To move up the value chain, Penang seeks convergence in products, technology and services. Accellent’s investment speaks directly to our vision of making Penang the location of choice for high-tech manufacturers.”


Accellent is privately owned and based in Wilmington, Mass.

 

 

St. Jude’s Penta Neurostimulation Lead OKin Japan

Medical device regulators in Japan have approved St. Jude Medical Inc.’s Penta surgical lead for neurostimulation therapy to manage chronic pain.


The Penta surgical lead addresses complex pain patterns such as low back pain and arm and leg pain, according to the company. In addition to Japan, the Penta lead is also is available in the United States, Europe, Australia and Canada.


Arranged in five columns, the Penta lead is designed to selectively stimulate nerve fibers associated with the patient’s area of pain without affecting other areas. The design also enables greater amounts of current to be delivered via the small electrodes, company officials said.

Penta can be used with the company’s Eon Mini spinal cord stimulator, which is approximately the size of a man’s watch. According to the company, the Eon Mini’s small design makes it well suited for smaller body frames.


“We are proud to be the first in the industry to offer physicians a neurostimulation lead with broad lateral coverage to help patients manage their chronic pain,” said William Phillips, president of St. Jude Medical Japan. “The Penta lead provides the most comprehensive spinal cord coverage available, and it is another powerful addition to our expanding line of neurostimulation products.”


The World Health Organization, in conjunction with the International Association for the Study of Pain, reports that as many as one in five people suffer from moderate to severe chronic pain. Neurostimulation (also called spinal cord stimulation) is used for managing chronic pain of the trunk and limbs and pain from back surgeries that have failed. Using mild electrical pulses to interrupt or mask the pain signals as they travel to the brain, the neurostimulator can be programmed to meet each individual patient’s needs.


St. Jude Medical is headquartered in St. Paul, Minn., and has four major focus areas that include cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.

—MPO Staff

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters